查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1594997

全球蛋白質定序市場

Protein Sequencing
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 89 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球蛋白質定序市場將達到 15 億美元

全球蛋白質定序市場預計 2023 年為 13 億美元，預計到 2030 年將達到 15 億美元，2023-2030 年分析期間複合年成長率為 2.9%。質譜技術是本報告分析的細分市場之一，預計複合年成長率為 2.7%，到分析期結束時將達到 9.735 億美元。在分析期間，Edman 分解技術部門的複合年成長率預計為 3.2%。

美國市場預估為3.386億美元，中國預期複合年成長率為2.7%

預計 2023 年美國蛋白質定序市場規模將達到 3.386 億美元。中國作為世界第二大經濟體，預計2030年市場規模將達2.449億美元，2023-2030年分析期間複合年成長率為2.7%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 2.4% 和 2.4%。在歐洲，德國的複合年成長率預計為 3.1%。

全球蛋白質定序市場 - 主要趨勢與促進因素總結

什麼是蛋白質定序以及為什麼需要它？

蛋白質定序是一種用於確定蛋白質氨基酸序列的分析過程，揭示有關其結構和功能的重要資訊。蛋白質定序中使用的主要技術包括埃德曼分解和質譜分析，使研究人員能夠識別、表徵和研究複雜生物樣品中的蛋白質組成。了解蛋白質序列可以深入了解細胞過程、疾病機制和基因表現，使該技術成為生物技術和藥物研究的基石。除了基礎科學之外，蛋白質定序在標靶治療、疫苗和診斷工具的開發中也發揮著至關重要的作用。確定蛋白質的精確結構和序列使研究人員和臨床醫生能夠識別與特定疾病相關的生物標記物，從而實現更個人化的醫學方法。蛋白質定序的應用範圍正在從蛋白質功能的基礎研究擴展到蛋白質體學、免疫學和合成生物學的應用。蛋白質定序的每一次突破都揭示了生物系統中新的​​複雜性，並提供了對蛋白質如何控制生命基本過程的更深入的了解。

技術創新如何形塑蛋白質序列？

最近的技術創新顯著提高了蛋白質定序的速度、準確性和成本，將其轉變為高通量過程。傳統的 Edman 分解雖然準確，但非常耗時且範圍有限，而當今基於質譜的方法可以快速處理大型蛋白質資料集。串聯式質譜質譜 (MS/MS) 等技術創新使研究人員能夠將胜肽分解成更小的片段並對序列測定，從而獲得更詳細、更全面的資料。此外，機器學習和生物資訊學的進步使得能夠更有效地分析大規模蛋白質資料，並提高高保真度繪製蛋白質圖譜的能力。奈米孔定序和基於次世代定序(NGS) 的蛋白質體學等新興技術有望實現更高的精度和覆蓋範圍，突破了蛋白質定序所能實現的界限。定序設備的不斷小型化和基於人工智慧的分析的整合使得蛋白質測序更容易實現並適用於各種科學領域。這些進步對藥物研究和個人化醫療產生了特殊的影響，其中快速且準確的蛋白質識別加速了藥物發現和精確診斷。

是什麼推動了對蛋白質定序解決方案的需求？

對蛋白質定序技術的需求受到跨產業的廣泛應用的推動，包括生物技術、製藥和環境研究。製藥公司正在使用蛋白質定序來發現新的治療標靶並表徵單株抗體等生技藥品，這對於治療癌症和自體免疫疾病非常重要。在農業生物技術中，蛋白質定序正在幫助開發抗蟲作物和更有效的食品加工酶解決方案。在免疫學領域，蛋白質定序也能夠研究免疫系統蛋白質，這是疫苗開發和自體免疫疾病研究的基礎。環境科學家使用蛋白質序列來研究微生物生態系統並深入了解生物多樣性和生物修復過程。臨床診斷產業也是蛋白質定序的主要消費者。蛋白質定序用於識別疾病特異性生物標記物，以實現更準確的診斷。總體而言，蛋白質定序的應用正在迅速擴大。因為該技術提供了需要準確且可操作的蛋白質資訊的多學科解決方案。

推動蛋白質定序市場成長的因素有哪些？

由於技術、商業性和社會因素的結合，蛋白質定序市場正在迅速擴大。新一代定序 (NGS) 技術的進步，加上運算能力的增強，使定序速度比以往更快、更具成本效益。製藥和生物技術產業對藥物發現和開發的高通量測序的需求是一個主要驅動力，特別是當生技藥品和生物學名藥作為治療劑變得越來越流行時。消費者對精準醫療的需求也促進了市場的成長。蛋白質定序在識別患者特異性蛋白質譜方面發揮重要作用，從而為標靶治療方案提供資訊。此外，與蛋白質組學和基因組學相關的學術和臨床研究的激增刺激了對能夠提供全面蛋白質分析的創新測序方法的需求。此外，慢性病的增加和對個人化治療的需求不斷成長正在推動對蛋白質組學的投資，其中蛋白質測序發揮重要作用。最後，生物技術和個人化醫療領域的政府支持政策和資金正在加速研究機構和私人公司的採用。這些因素共同凸顯了蛋白質定序在提昇科學和臨床能力、確保未來持續成長和相關性方面所發揮的重要作用。

部分

技術（質譜、埃德曼分解）；應用（生物治療、基因工程、其他應用）；最終用途（學術機構/研究中心、製藥/生物技術公司、其他最終用途）

受訪企業舉例（共34家）

  • Agilent Technologies
  • Bioinformatics Solution
  • Charles River Laboratories
  • Proteome Factory
  • Rapid Novor
  • Selvita
  • SGS（SA）
  • Shimadzu Corp.
  • Thermo Fischer Inc.
  • Water Corporation

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他領域

第4章 比賽

簡介目錄
Product Code: MCP22661

Global Protein Sequencing Market to Reach US$1.5 Billion by 2030

The global market for Protein Sequencing estimated at US$1.3 Billion in the year 2023, is expected to reach US$1.5 Billion by 2030, growing at a CAGR of 2.9% over the analysis period 2023-2030. Mass Spectrometry Technology, one of the segments analyzed in the report, is expected to record a 2.7% CAGR and reach US$973.5 Million by the end of the analysis period. Growth in the Edman Degradation Technology segment is estimated at 3.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$338.6 Million While China is Forecast to Grow at 2.7% CAGR

The Protein Sequencing market in the U.S. is estimated at US$338.6 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$244.9 Million by the year 2030 trailing a CAGR of 2.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.4% and 2.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR.

Global Protein Sequencing Market - Key Trends & Drivers Summarized

What Is Protein Sequencing and Why Is It Essential?

Protein sequencing is the analytical process used to determine the amino acid sequence of proteins, unlocking crucial information about their structure and function. The primary techniques utilized in protein sequencing include Edman degradation and mass spectrometry, which allow researchers to identify, characterize, and study protein compositions in complex biological samples. Understanding protein sequences provides insights into cellular processes, disease mechanisms, and genetic expression, making this technology a cornerstone in biotechnology and pharmaceutical research. Beyond basic science, protein sequencing also plays a pivotal role in developing targeted therapies, vaccines, and diagnostic tools. By identifying the exact structure and sequence of proteins, researchers and clinicians can pinpoint biomarkers associated with specific diseases, enabling more personalized approaches in medicine. The scope of protein sequencing has expanded from foundational studies of protein function to applications in proteomics, immunology, and synthetic biology. With each breakthrough, protein sequencing reveals new complexities of biological systems, offering a deeper understanding of how proteins govern the essential processes of life.

How Are Technological Innovations Shaping Protein Sequencing?

Recent technological advancements have significantly enhanced the speed, accuracy, and affordability of protein sequencing, transforming it into a high-throughput process. Traditional Edman degradation, while precise, was slow and limited in scope, but today’s mass spectrometry-based methods can process large protein datasets rapidly. Innovations such as tandem mass spectrometry (MS/MS) allow researchers to sequence peptides by breaking them down into smaller fragments, providing more detailed and comprehensive data. Furthermore, advancements in machine learning and bioinformatics have enabled more effective analysis of large-scale protein data, enhancing the ability to map proteins with high fidelity. Emerging techniques, including nanopore sequencing and next-generation sequencing (NGS)-based proteomics, promise further accuracy and scope, pushing the boundaries of what protein sequencing can achieve. With the ongoing miniaturization of sequencing instruments and the integration of AI-based analysis, protein sequencing is becoming more accessible and applicable to diverse scientific fields. These advancements are particularly impactful in pharmaceutical research and personalized medicine, where rapid, accurate protein identification can accelerate drug discovery and precision diagnostics.

Who Is Driving the Demand for Protein Sequencing Solutions?

The demand for protein sequencing technologies is being driven by a wide range of applications across industries, including biotechnology, pharmaceuticals, and environmental research. Pharmaceutical companies are leveraging protein sequencing to discover novel therapeutic targets and to characterize biologics like monoclonal antibodies, which are crucial in cancer and autoimmune disease treatment. In agricultural biotechnology, protein sequencing helps develop pest-resistant crops and more efficient enzyme solutions for food processing. The field of immunology also benefits from protein sequencing, as it enables the study of immune system proteins, which is fundamental in vaccine development and autoimmune disease research. Environmental scientists utilize protein sequencing to study microbial ecosystems, gaining insights into biodiversity and bioremediation processes. The clinical diagnostics industry also represents a major consumer of protein sequencing, where it is used to identify disease-specific biomarkers for more accurate diagnoses. Overall, the applications of protein sequencing are expanding rapidly, as this technology provides solutions that span multiple fields, each requiring precise and actionable protein information.

What Factors Are Driving Growth in the Protein Sequencing Market?

The protein sequencing market is expanding rapidly due to a combination of technological, commercial, and societal factors. Advances in next-generation sequencing (NGS) technology, coupled with increasing computational capabilities, are enabling more rapid and cost-effective sequencing than ever before. The demand from pharmaceutical and biotechnology industries for high-throughput sequencing for drug discovery and development is a major driver, particularly as biologics and biosimilars gain popularity as therapeutic agents. Consumer demand for precision medicine is also contributing to market growth, as protein sequencing is fundamental in identifying patient-specific protein profiles that inform targeted treatment options. Additionally, the surge in academic and clinical research related to proteomics and genomics is stimulating the need for innovative sequencing methods that can provide comprehensive protein analysis. Furthermore, the increasing prevalence of chronic diseases and the growing need for personalized treatments are driving investment in proteomics, where protein sequencing plays an indispensable role. Lastly, supportive government policies and funding in the fields of biotechnology and personalized healthcare are accelerating adoption across research institutions and private sector organizations. Together, these factors underscore the critical role of protein sequencing in advancing scientific and clinical capabilities, ensuring its continued growth and relevance in the years ahead.

SCOPE OF STUDY:

The report analyzes the Protein Sequencing market in terms of US$ Thousand by the following Application; End-Use; Technology, and Geographic Regions/Countries:

Segments:

Technology (Mass Spectrometry, Edman Degradation); Application (Biotherapeutics, Genetic Engineering, Other Applications); End-Use (Academic Institutes & Research Centers, Pharma & Biotech Companies, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 34 Featured) -

  • Agilent Technologies
  • Bioinformatics Solution
  • Charles River Laboratories
  • Proteome Factory
  • Rapid Novor
  • Selvita
  • SGS (SA)
  • Shimadzu Corp.
  • Thermo Fischer Inc.
  • Water Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Protein Sequencing - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Demand for Precision Medicine and Personalized Therapies Drives Growth in Protein Sequencing Technologies
    • Rising Use of Protein Sequencing in Drug Discovery and Development Expands Addressable Market for Biotechnology and Pharma Applications
    • Advances in Mass Spectrometry and High-Throughput Sequencing Propel Innovations and Efficiency in Protein Sequencing Processes
    • Growing Need for Proteomic Data to Understand Complex Diseases Spurs Adoption of Protein Sequencing in Biomedical Research
    • Integration of Artificial Intelligence and Machine Learning in Protein Sequencing Enhances Data Analysis, Accuracy, and Predictive Insights
    • Expanding Applications of Protein Sequencing in Biomarker Discovery Accelerates Demand in Cancer, Cardiovascular, and Neurological Disease Studies
    • Increasing Prevalence of Chronic Diseases and Personalized Treatment Approaches Drive Market Growth for Advanced Protein Analysis Techniques
    • Miniaturization and Automation of Protein Sequencing Tools Generate Opportunities for Point-of-Care Diagnostics and Clinical Applications
    • Rising Demand for Proteomic Data in Agricultural Biotechnology Propels Use of Protein Sequencing in Crop and Livestock Improvement Programs
    • Growing Adoption of Next-Generation Sequencing (NGS) and Single-Molecule Sequencing Drives Technological Advancements in Protein Sequencing
    • Increased Awareness of Protein Sequencing in Environmental and Marine Biology Expands Applications Beyond Traditional Life Sciences
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Protein Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Protein Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Protein Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Mass Spectrometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Mass Spectrometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Mass Spectrometry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Edman Degradation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Edman Degradation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Edman Degradation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Biotherapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Biotherapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Biotherapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Genetic Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Genetic Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Genetic Engineering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Academic Institutes & Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Academic Institutes & Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Academic Institutes & Research Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 28: World Protein Sequencing Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Protein Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2014, 2024 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Protein Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2014, 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Protein Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2014, 2024 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Protein Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Protein Sequencing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Protein Sequencing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Protein Sequencing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2014, 2024 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Protein Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: France 16-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2014, 2024 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: France 16-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Protein Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2014, 2024 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2014, 2024 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Protein Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: UK 16-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2014, 2024 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Rest of Europe Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: Rest of Europe 16-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2014, 2024 & 2030
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Rest of Europe Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: Rest of Europe 16-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: Rest of Europe 16-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Protein Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Asia-Pacific 16-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2014, 2024 & 2030
    • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Asia-Pacific Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Asia-Pacific 16-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Asia-Pacific 16-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 131: Rest of World Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of World Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of World 16-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of World Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of World 16-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of World 16-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION